# Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules in Healthy Volunteers

> **NCT01408316** · PHASE1 · COMPLETED · sponsor: **Cascadian Therapeutics Inc.** · enrollment: 39 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** PX-866

## Key facts

- **NCT ID:** NCT01408316
- **Lead sponsor:** Cascadian Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-10
- **Final completion:** 2012-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408316, "Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01408316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*